Adverum Biotechnologies, Inc.

NasdaqCM:ADVM 株式レポート

時価総額:US$144.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Adverum Biotechnologies マネジメント

マネジメント 基準チェック /34

Adverum Biotechnologies'の CEO はLaurent Fischerで、 Jun2020年に任命され、 の在任期間は 4.17年です。 の年間総報酬は$ 1.55Mで、 43.4%給与と56.6%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.34%を直接所有しており、その価値は$ 486.55K 。経営陣と取締役会の平均在任期間はそれぞれ2.6年と4.3年です。

主要情報

Laurent Fischer

最高経営責任者

US$1.5m

報酬総額

CEO給与比率43.4%
CEO在任期間4.3yrs
CEOの所有権0.3%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

We're Keeping An Eye On Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Feb 24
We're Keeping An Eye On Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

Sep 07
We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

Adverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10

Aug 11

Adverum gains 13% to reach three-month high after Truist upgrade

Jul 07

We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

May 12
We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Jul 17
We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Adverum Biotechnologies: An Uncertain Path Forward

May 05

Adverum Bio presents long-term data from ADVM-022 trial in wet AMD

May 03

We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Apr 06
We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Don't Ignore The Fact That This Insider Just Sold Some Shares In Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Feb 13
Don't Ignore The Fact That This Insider Just Sold Some Shares In Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Adverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapy

Feb 02

Trade Alert: The Independent Chairman Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM), C. Machado, Has Just Spent US$115k Buying 15% More Shares

Jan 22
Trade Alert: The Independent Chairman Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM), C. Machado, Has Just Spent US$115k Buying 15% More Shares

Adverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated Market

Jan 11

Adverum Biotechnologies announces new GMP gene therapy manufacturing facility

Jan 07

How Much Are Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Spending On Buying Shares?

Dec 31
How Much Are Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Spending On Buying Shares?

CEO報酬分析

Adverum Biotechnologies の収益と比較して、Laurent Fischer の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$100m

Mar 31 2024n/an/a

-US$113m

Dec 31 2023US$2mUS$672k

-US$117m

Sep 30 2023n/an/a

-US$126m

Jun 30 2023n/an/a

-US$133m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$3mUS$646k

-US$155m

Sep 30 2022n/an/a

-US$156m

Jun 30 2022n/an/a

-US$154m

Mar 31 2022n/an/a

-US$155m

Dec 31 2021US$9mUS$621k

-US$146m

Sep 30 2021n/an/a

-US$149m

Jun 30 2021n/an/a

-US$138m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020US$22mUS$327k

-US$118m

報酬と市場: Laurentの 総報酬 ($USD 1.55M ) は、 US市場 ($USD 667.49K ) の同規模の企業の平均を上回っています。

報酬と収益: Laurentの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Laurent Fischer (60 yo)

4.3yrs

在職期間

US$1,546,477

報酬

Dr. Laurent Fischer, M.D., serves as Chair of the Board of Teal Omics Inc. He has been the Independent Supervisory Director of Atai Life Science N.V. since May 2024. He is Advisor of FORM Life Ventures. He...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Laurent Fischer
President4.3yrsUS$1.55m0.34%
$ 488.7k
Linda Rubinstein
CFO, Principal Financial Officer & Principal Accounting Officer1.8yrsUS$2.30m0.048%
$ 69.4k
Kishor Soparkar
Chief Operating Officer3.3yrsUS$903.02k0.13%
$ 192.9k
Setareh Seyedkazemi
Chief Development Officer2.7yrsUS$799.36k0.026%
$ 37.2k
Rabia Ozden
Chief Medical Officerless than a yearUS$94.20k0%
$ 0
R. Ramelmeier
Chief Technology Officer1.1yrsデータなしデータなし
Romuald Corbau
Chief Scientific Officerless than a yearデータなしデータなし
John Rakow
Senior VP & General Counsel3.2yrsUS$1.33m0.031%
$ 45.0k
Dena House
Chief People Officer5.1yrsデータなしデータなし
Carla Fiankan
Senior Vice President of Regulatory Affairs2.7yrsデータなしデータなし
Michael Steel
Senior Vice President of Quality2.9yrsデータなしデータなし
Heikki Jouttijarvi
Senior VP of Manufacturing & Supply Chain Management and Head of Technical Operationsno dataデータなしデータなし

2.7yrs

平均在職期間

56.5yo

平均年齢

経験豊富な経営陣: ADVMの経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Laurent Fischer
President4.3yrsUS$1.55m0.34%
$ 488.7k
James Scopa
Independent Director5.3yrsUS$111.70k0.050%
$ 71.7k
Scott Whitcup
Independent Director4.4yrsUS$106.70k0%
$ 0
David Boyer
Scientific Advisory Board Memberno dataデータなしデータなし
C. Machado
Independent Chairman7.5yrsUS$163.80k0.042%
$ 61.2k
Jeffrey Heier
Scientific Advisory Board Memberno dataデータなしデータなし
Reed Tuckson
Independent Director3.6yrsUS$99.20k0%
$ 0
Dawn Svoronos
Independent Director3.8yrsUS$106.70k0.024%
$ 34.7k
Mark Lupher
Independent Director5.3yrsUS$99.20k0.063%
$ 90.2k
Charles Wykoff
Scientific Advisory Board Memberno dataデータなしデータなし
Arshad Khanani
Scientific Advisory Board Memberno dataデータなしデータなし
Szilard Kiss
Directorless than a yearデータなしデータなし

4.3yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: ADVMの 取締役会経験豊富 であると考えられます ( 4.3年の平均在任期間)。